EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.23.38 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Met-Phe + Leu-Ser-Phe-Pro-(gamma-aminobutyryl)-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-(gamma-aminobutyryl)-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-(gamma-aminobutyryl)-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Met-Phe + Leu-Ser-Phe-Pro-(gamma-aminobutyryl)-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid |
- |
? |
3.4.23.38 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Nle-Phe + Leu-Ser-Phe-Pro-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid |
- |
? |
3.4.23.38 | Ala-Leu-Glu-Arg-Thr-Phe-Leu-Ser-Phe-Pro-Thr + H2O |
- |
Plasmodium falciparum |
Ala-Leu-Glu-Arg-Thr-Phe + Leu-Ser-Phe-Pro-Thr |
- |
? |
3.4.23.38 | EDANS-CO-CH2-CH2-CO-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-Dap-(DABCYL)-OH + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | Hemoglobin + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | hemoglobin alpha-chain + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | human hemoglobin + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | Leu-Glu-Arg-Ile-Phe-(p-nitro)Phe-Ser-Phe + H2O |
- |
Plasmodium falciparum |
Leu-Glu-Arg-Ile-Phe + (p-nitro)Phe-Ser-Phe |
- |
? |